Size‐Dependent Cascade Enhancement of T 1 ‐T 2 Dual‐Modal MRI in Tumors
Advanced Materials · 2025
DOI: 10.1002/adma.202414201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Yanyun Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Precision and Intelligent Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026, China. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Contrast Media, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Currently, there is no conclusive evidence indicating that in situ self‐assembled Gd nanostructures of varying sizes demonstrate distinct T 1 and T 2 signal enhancement capabilities. Furthermore, it remains uncertain whether size adjustment can effectively achieve enhanced T 1 ‐T 2 dual‐modal MRI. To address these uncertainties, a two‐step in situ self‐assembly strategy is developed. This approach began with a small‐sized nanoprobe, Gd‐TCO‐P, with a hydrodynamic diameter (dH) of 16 ± 3 nm. This nanoprobe underwent alkaline phosphatase (ALP) cleavage and self‐assembled intracellularly into short nanofibers termed Gd‐NFs (dH: 200 ± 51 nm). The subsequent introduction of tetrazine‐tetrazine crosslinked these Gd‐NFs, leading to the formation of larger two‐stage dendritic nanofibers known as Gd‐TS‐NFs (dH: 4371 ± 236 nm). This process achieves size‐dependent enhancement of both T 1 and T 2 signals, which is validated through both in vitro and in vivo experiments, enabling precise long‐term imaging of ALP‐overexpressing tumors. This study not only provides valuable insights into the relationship between the size of in situ formed Gd nanostructures and T 1 /T 2 MRI contrast enhancement, but also suggests a promising strategy for clinical applications of T 1 ‐T 2 dual‐modal MRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Precision and Intelligent Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026, China.
- Department of Nuclear Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China.
- The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230026, China.
- Department of Chemistry and Chemical Engineering, Hefei Normal University, Hefei, Anhui, 230061, China.
ORCID-Profile: Yue Yuan
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Yang, Y., Zheng, Y., Tong, T., Dong, J., Zhao, M., Zhang, G., Yu, Z., Dong, L., Jiang, J., & Yuan, Y. (2025). Size‐Dependent Cascade Enhancement of T 1 ‐T 2 Dual‐Modal MRI in Tumors. Advanced Materials. https://doi.org/10.1002/adma.202414201
Vancouver
Yang Y, Zheng Y, Tong T, Dong J, Zhao M, Zhang G, et al. Size‐Dependent Cascade Enhancement of T 1 ‐T 2 Dual‐Modal MRI in Tumors. Advanced Materials. 2025. doi:10.1002/adma.202414201
BibTeX
@article{Yang2025,
author = {Yang, Yanyun and Zheng, Yifan and Tong, Tong and Dong, Jiajing and Zhao, Miaoxin and Zhang, Guangtao and Yu, Zian and Dong, Ling and Jiang, Jinhui and Yuan, Yue},
title = {Size‐Dependent Cascade Enhancement of T 1 ‐T 2 Dual‐Modal MRI in Tumors},
journal = {Advanced Materials},
year = {2025},
doi = {10.1002/adma.202414201}
}
EUVIMED